Assessing AI Algorithms: Quality Assessment of Medical AI by and for the Healthcare Field | SGInnovate

SGInnovate Website Maintenance Notice

SGInnovate.com & STARS.SGInnovate.com will be temporarily unavailable from 05 Dec 2022, 22:00 to 06 Dec 2022, 08:00 (SGT).

We apologise for any inconvenience and thank you for your patience during this time.

June 22 2022

Location

Physical Event
32 Carpenter Street, Singapore 059911, Singapore
Singapore

ENDED

Assessing AI Algorithms: Quality Assessment of Medical AI by and for the Healthcare Field

Presented by SGInnovate and Netherlands Innovation Network

There is no denying the promising opportunities for Artificial Intelligence (AI) and Machine Learning (ML) in healthcare. But the introduction goes slowly, and that is largely because there is always a desire and demand by the healthcare field to carefully assess these complex data-driven AI algorithms before they are to be applied and disseminated in daily healthcare. How can we guarantee that these AI applications live up to our desired standards, and how can we assess their quality in healthcare? The Dutch Ministry of Health, Welfare and Sport asked more than 50 field experts and healthcare professionals from all possible disciplines to research what they consider good professional conduct in developing, testing, and implementing AI algorithms in the healthcare sector, including in the public and prevention healthcare sector. The research, led by Prof Dr Carl Moons, resulted in a publicly accessible set of criteria and an online course that healthcare organisations and providers, citizens, patients, insurance companies and policymakers, AI developers and manufacturers will benefit from. This research also enlarges trust and uniformity when developing, purchasing, using or having AI-driven devices used on them.

In this session, Prof Dr Carl Moons will share more about the guidelines for assessing AI algorithms, their process and how they are used to accelerate the introduction of MedTech innovations in the Dutch nationwide health technology infrastructure of HI-NL (www.healthinnovation.nl) to meet end-user needs.

Date: 22 June 2022, Wednesday
Time: 10:30am - 12:30pm
Venue: 32 Carpenter Street, Singapore 059911

Event Programme:
10:30am – 11:00am: Registration
11:00am – 11:30am: Presentation on Assessing AI-algorithms with Prof Dr Carl Moons: A Published Guideline for Quality Assessment of Medical AI by and for the Healthcare Field
11:30am – 12:00pm: Fireside Chat and Q&A with

  • Prof Dr KGM (Carl) Moons, Julius Center for Health Sciences and Primary Care, UMC Utrecht, The Netherlands
  • Moderator: Suchitra Narayan, Director - Advanced Manufacturing, SGInnovate
12:00pm – 12:30pm: Networking

Speaker's Profile:
Prof Dr KGM (Carl) Moons, Julius Center for Health Sciences and Primary Care, UMC Utrecht, The Netherlands
image

Prof Dr Carl Moons is a professor of Clinical Epidemiology and former director of research at the Julius Center at the UMC Utrecht (www.juliuscenter.nl). He is the UMC Utrecht figurehead on Artificial Intelligence. He is also affiliated with VanderBilt University (US) and Oxford University (UK) and is convenor of the Cochrane Prognosis Methods Group. He is chair of the Dutch ‘Reporting and Expert Center for Side-effects of Implants’ (Meldpunt en Expertisecentrum Bijwerkingen Implantaten: MEBI). He is also co-initiator and co-director of the new nationwide and unique infrastructure - Health Innovation Netherlands (HI-NL; www.healthinnovation.nl). HI-NL brings all stakeholders in the healthcare sector together at the early stage to bring medical devices, ranging from robotics, medical diagnostic and screening tests, biomarkers, decision aids, AI algorithms and eHealth applications, responsibly and profitably to the health(care) system. 

 

Prof Moons chaired the Royal Netherlands Academy of Arts and Sciences (KNAW) committee, ‘Evaluation of New Technology in Healthcare’. He is the senior author of the guideline for developing and introducing safe, effective and transparent AI-based algorithms in healthcare. He chaired during the Covid-19 pandemic the national advisory committee on ‘Digital Solutions to Control Covid-19’. His scientific career (>600 peer-reviewed publications, books and book chapters) focuses on research on the real impact of medical innovations, ranging from drugs, robotics, medical tests, eHealth and AI algorithms, for patients, citizens and healthcare. In this respect, he is a principal investigator in numerous international clinical studies and networks on medical research and innovation, funded by various international organisations (EU, NHS, NIH). 

Moderator's Profile:
Suchitra Narayan, Director - Advanced Manufacturing, SGInnovate

image
Suchi has almost 20 years of experience in venture building, product development, business strategy and corporate partnerships across global markets, with a strong focus in Australia and Asia. In her current capacity as Director - Venture Building, Suchi acts as a lead to new projects, provides business-building guidance in areas such as business planning, commercial strategy and scaling growth to new and ‘built-from-scratch’ Deep Tech startups. 

Prior to SGInnovate, she was Vice President, Sales and Service at Gartner, where she was providing strategic advisory to APAC leaders on go-to-market, business development as well as commercial strategies in Asia. An engineer by training, she has a particular interest in Robotics, Health-tech and Artificial Intelligence. She is also passionate about supporting more women in pursuing an education and career in Science, Technology, Engineering and Mathematics.

Topics: AI / Machine Learning / Deep Learning, MedTech / HealthTech / BioTech

Industry: Health and BioMedical Sciences